Patents by Inventor Antoine Beret

Antoine Beret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 2,4 diamino-quinoline as new anticancer agents
    Patent number: 10722505
    Abstract: The present invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicaments. The active compounds of the present invention are useful for the treatment and prevention of proliferative neoplastic and non-neoplastic diseases.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: July 28, 2020
    Assignee: GENOSCIENCE PHARMA
    Inventors: Firas Bassissi, Antoine Beret, Sonia Brun, Jérôme Courcambeck, Clarisse Dubray, Gregory Nicolas, Philippe Halfon
  • Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases
    Patent number: 10577362
    Abstract: This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein which exhibit strong inhibition effects on various cancer cell lines. The compounds disclosed herein are useful for the treatment of proliferative diseases, including neoplastic diseases such as cancer and non-neoplastic disorders such as rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing compounds of Formula I and at least one carrier, diluent or excipient and optionally one or more additional therapeutically active agents, including anticancer agents. This application also discloses methods for treating a proliferative disease, including neoplastic diseases such as cancer and non-neoplastic disorders such as rheumatoid arthritis.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: March 3, 2020
    Assignee: GENOSCIENCE PHARMA
    Inventors: Sonia Brun, Antoine Beret, Firas Bassissi, Philippe Halfon, Jérôme Courcambeck
  • SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW ANTICANCER AGENTS
    Publication number: 20190314359
    Abstract: The present invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicaments. The active compounds of the present invention are useful for the treatment and prevention of proliferative neoplastic and non-neoplastic diseases.
    Type: Application
    Filed: October 26, 2015
    Publication date: October 17, 2019
    Inventors: Firas BASSISSI, Antoine BERET, Sonia BRUN, Jérôme COURCAMBECK, Clarisse DUBRAY, Gregory NICOLAS, Philippe HALFON
  • SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20190144437
    Abstract: This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein which exhibit strong inhibition effects on various cancer cell lines. The compounds disclosed herein are useful for the treatment of proliferative diseases, including neoplastic diseases such as cancer and non-neoplastic disorders such as rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing compounds of Formula I and at least one carrier, diluent or excipient and optionally one or more additional therapeutically active agents, including anticancer agents. This application also discloses methods for treating a proliferative disease, including neoplastic diseases such as cancer and non-neoplastic disorders such as rheumatoid arthritis.
    Type: Application
    Filed: May 4, 2017
    Publication date: May 16, 2019
    Applicant: GENOSCIENCE PHARMA
    Inventors: Sonia BRUN, Antoine BERET, Firas BASSISSI, Philippe HALFON, Jérôme COURCAMBECK
  • Quinolines derivatives as novel anticancer agents
    Patent number: 10179770
    Abstract: The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 15, 2019
    Assignee: GENOSCIENCE PHARMA
    Inventors: Jerome Courcambeck, Philippe Halfon, Firas Bassissi, Sonia Brun, Gregory Nicolas, Antoine Beret, Serge Petit, Claire Camus, Jean Pierre Nallet
  • QUINOLINES DERIVATIVES AS NOVEL ANTICANCER AGENTS
    Publication number: 20160280653
    Abstract: The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 29, 2016
    Inventors: Jerome COURCAMBECK, Philippe HALFON, Firas BASSISSI, Sonia BRUN, Gregory NICOLAS, Antoine BERET, Serge PETIT, Claire CAMUS, Jean Pierre NALLET
  • NOVEL COMPOSITION FOR TREATING THE SIDE EFFECTS OF ANTICANCER TREATMENTS
    Publication number: 20100310674
    Abstract: The invention relates to novel compositions, particularly pharmaceutical, comprising, as active ingredients, at least one cytotoxic agent and at least one cholest-4-en-3-one oxime derivative.
    Type: Application
    Filed: October 30, 2008
    Publication date: December 9, 2010
    Applicant: TROPHOS
    Inventors: Rebecca Pruss, Thierry Bordet, Jean-Louis Abitbol, Antoine Beret